Skip to main content
Industry News
FDA clears Pops! Diabetes' blood glucose monitoring system

The FDA has granted Pops! Diabetes Care clearance to market its Pops! one Blood Glucose Monitoring System, which enables review of blood glucose trends by users and data sharing with health care providers and family members. The system, which uses a coaching app to interact with users, is expected to be released early next year.

Full Story: